Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyVitiligoTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyVitiligoTeam Member asked a question 💭
Southfield, MI
July 10, 2025
 · 
Be the first to react
A MyVitiligoTeam Member

Same, the Opzelura did work at first on my hands along with light treatments. It cleared almost all the way up then started returning to which it was worse than when I started. Are you saying you used the oral 50mg Litfulo?

September 18, 2025
A MyVitiligoTeam Member

I used it for about 9 months but continued my light treatment 2-3x a week. I had hundreds of spots but the light treatment helped significantly for me before I tried Opzelura. I only have a few spots on my face and neither the light treatment or the cream worked. The Opzelura did nothing for my hands and I have continued the light treatment but still have minimal to no facial recovery and some white spots still on my hands. The light treatment helped the rest of my body significantly.

September 18, 2025
A MyVitiligoTeam Member

You know what... I felt the same way. I used it for several months my hands got better then suddenly became active in the middle of using it. When it came back it was way worse than it had ever been. You just confirmed it for me.

July 30, 2025
A MyVitiligoTeam Member

Opzelura has not changed much on me. Helps the face and is easy on the skin, but the hands actually worsen with it for me.

July 29, 2025
MyVitiligoTeam

Ruxolitinib (Opzelura) is a relatively new FDA-approved treatment for vitiligo in people aged 12 and older with nonsegmental vitiligo. It's applied as a topical cream and works by blocking JAK proteins that trigger immune system attacks on melanocytes (pigment-producing cells).

Clinical trials showed promising results - Show Full Answer

Ruxolitinib (Opzelura) is a relatively new FDA-approved treatment for vitiligo in people aged 12 and older with nonsegmental vitiligo. It's applied as a topical cream and works by blocking JAK proteins that trigger immune system attacks on melanocytes (pigment-producing cells).

Clinical trials showed promising results - after 6 months, about 30% of users saw at least 75% improvement in facial repigmentation, compared to only 10% who used a placebo cream. Since it's applied directly to the skin, this treatment typically has a lower risk of serious side effects compared to oral medications. While results may take a few months to appear, some people notice improvements sooner. It's important to discuss with your dermatologist if this treatment option might be right for you.

July 10, 2025

Related Questions

View All
A MyVitiligoTeam Member asked a question 💭
Southfield, MI

A MyVitiligoTeam Member asked a question 💭
Southfield, MI

A MyVitiligoTeam Member asked a question 💭
Southfield, MI